Bitwise has introduced the first exchange traded product (ETP) tracking the Lighter platform's LIT token, now trading on Deutsche Börse Xetra under ticker BLIT. This ETP allows European investors to gain exposure to the decentralized trading platform without managing crypto wallets, with an annual fee of 0.85%. LIT has surged over 580% since March, reflecting strong recovery and growing interest in blockchain markets that blend crypto with traditional finance. Bitwise plans to activate staking rewards for the ETP once assets under management grow sufficiently, marking a step forward in integrating crypto assets with conventional investment products.
Bitwise's launch of the first Lighter ETP and LIT's 580% rebound offer context for cryptocurrency market activity. For readers following crypto assets, here is Pluang's market snapshot as of Sep 24, 2026 04:21 WIB: out of 50 major cryptocurrencies priced on Pluang, 5 rose and 44 fell today. Notable movers include BAL (Balancer) at Rp16.297 with an 11.14% increase, ONE (Harmony) at Rp51 down 15.04%, and FIL (Filecoin) at Rp16.456 down 9.65%.
NeoVolta reported a weak Q4 with revenue dropping to $13,460 and a loss of $0.24 per share, missing analyst expectations. Despite this, full-year revenue rose 58% to $13.3 million as the company expanded beyond residential markets. The Q4 loss widene...
BlackBerry is expected to report Q3 earnings with an EPS of $0.04 and revenue around $143.55 million, in line with company guidance. The company has a strong track record of beating earnings estimates, driven by growth in its QNX automotive software ...
On September 23, Jaguar Health's stock plunged about 74%, reversing a prior gain, without any confirmed negative news. Alkami Technology's shares fell 19% after ending a strategic review and deciding to remain independent. Other stocks like Cullinan ...
Wheeler REIT (WHLR) surged 190.91% after a 1-for-9 reverse stock split, though no new catalyst was confirmed. Artelo Biosciences (ARTL) rose 74% following a provisional patent application for its obesity drug candidate ART27.13, based on early mouse ...
Costco Wholesale announced $93.9 billion in net sales for its fiscal Q4, up 11.3% from last year, with comparable sales rising 9.4%. The full earnings report on September 24 will reveal membership fees, total revenue, expenses, and profit details. An...
